Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1975 Jan;31(1):15–24. doi: 10.1038/bjc.1975.3

Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.

A Ghaffar, R T Cullen, M A Woodruff
PMCID: PMC2009347  PMID: 1156505

Abstract

Administration of C. parvum to both intact and thymectomized mice resulted in the appearance in the peritoneal exudate of cells which inhibited tumour growth in vitro. This effect was mediated by intact, viable adherent cells, which it seems reasonable to categorize as macrophages, and was contingent on contact between the effector and target cells. No co-operation was observed between lymph node cells from C. parvum treated mice and peritoneal exudate cells from normal mice.

Full text

PDF
15

Images in this article

19Fig. 3
on p.19

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley M. P., Hardy D. Tumour resistance of mice infected with salmonella enteritidis 11RX. The role of peritoneal exudate cells. Aust J Exp Biol Med Sci. 1973 Dec;51(6):801–809. doi: 10.1038/icb.1973.76. [DOI] [PubMed] [Google Scholar]
  2. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  3. Evans R., Alexander P. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. Immunology. 1972 Oct;23(4):615–626. [PMC free article] [PubMed] [Google Scholar]
  4. Evans R., Cox H., Alexander P. Immunologically specific activation of macrophages armed with the specific macrophage arming factor (SMAF). Proc Soc Exp Biol Med. 1973 May;143(1):256–259. doi: 10.3181/00379727-143-37298. [DOI] [PubMed] [Google Scholar]
  5. Evans R., Grant C. K., Cox H., Steele K., Alexander P. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor. J Exp Med. 1972 Nov 1;136(5):1318–1322. doi: 10.1084/jem.136.5.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ghaffar A., Cullen R. T., Dunbar N., Woodruff M. F. Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum. Br J Cancer. 1974 Mar;29(3):199–205. doi: 10.1038/bjc.1974.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol. 1972 Jan 12;235(54):48–50. doi: 10.1038/newbio235048a0. [DOI] [PubMed] [Google Scholar]
  8. Keller R. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J Exp Med. 1973 Sep 1;138(3):625–644. doi: 10.1084/jem.138.3.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Keller R., Hess M. W. Tumour growth and non-specific immunity in rats: the mechanisms involved in inhibition of tumour growth. Br J Exp Pathol. 1972 Oct;53(5):570–577. [PMC free article] [PubMed] [Google Scholar]
  10. Keller R. Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors. Immunology. 1974 Aug;27(2):285–298. [PMC free article] [PubMed] [Google Scholar]
  11. Olivotto M., Bomford R. In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum. Int J Cancer. 1974 Apr 15;13(4):478–488. doi: 10.1002/ijc.2910130406. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES